Alexis Shawver Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 197 Brocklesby Rd, Caledonia, OH 43314 Phone: 740-725-5400 |
News Archive
xG Health Solutions, a leading health care redesign and optimization company that is powered by intellectual property and expertise from Geisinger Health System, has successfully launched its learning solution, xG Health Learning, to support care management and provider training.
States that set high staffing standards for elder care in nursing homes are the only ones that come close to having enough staff nurses to prevent serious safety violations, according to a new study by a professor in the UCSF School of Nursing.
e-Therapeutics plc announces that it has started a second phase I clinical trial of its anti-cancer drug ETS2101. This trial will enrol up to 45 patients with a variety of solid tumours at two UK centres, St James's University Hospital in Leeds and the Northern Centre for Cancer Care at the Freeman Hospital in Newcastle.
Androgen deprivation therapy (ADT) is a common treatment option for patients with advanced stage prostate cancer. But nearly 80 percent of patients who receive ADT report experiencing hot flashes during and after treatment. Moffitt Cancer Center researchers are working to determine what genetic factors and other characteristics might make prostate cancer patients more likely to experience hot flashes during and after therapy.
The U.S. Food and Drug Administration granted accelerated approval of a Perjeta- (pertuzumab) regimen for neoadjuvant treatment (use before surgery) in people with high-risk, HER2-positive early stage breast cancer.
› Verified 3 days ago